Tetranectin knockout mice develop features of Parkinson disease

Er-song Wang1, Xiao-ping Zhang, Hui-bin Yao

  • 1Department of Neurosurgery, Jinshan Hospital, Fudan University, Shanghai, China.

Abstract

Insights

Mice lacking tetranectin (TN) developed Parkinson disease (PD) symptoms, including motor deficits and Lewy body-like inclusions. This new TN(-/-) mouse model aids Parkinson disease research.

Area of Science:

  • Neuroscience
  • Genetics
  • Pathology

Background:

  • Alpha-synuclein aggregation into Lewy bodies (LBs) is implicated in Parkinson disease (PD) pathogenesis.
  • Loss of midbrain dopaminergic neurons is a hallmark of PD.
  • A lack of suitable animal models hinders the study of LB formation and PD.

Purpose of the Study:

  • To establish and characterize a novel mouse model for Parkinson disease.
  • To investigate the role of tetranectin (TN) in PD pathogenesis.
  • To evaluate the utility of the TN(-/-) mouse model for studying LB formation and neuroprotection.

Main Methods:

  • Generation of a tetranectin (TN) gene knockout mouse model (TN(-/-)).
  • Assessment of behavioral and histopathological features relevant to PD.
  • Analysis of motor deficits, LB-like inclusions, dopaminergic neuron counts, and dopamine terminal loss.

Main Results:

  • Aged TN(-/-) mice exhibited motor impairments, including rigidity and bradykinesia.
  • TN(-/-) mice showed increased α-synuclein-positive LB-like inclusions in the substantia nigra pars compacta (SNc).
  • Reduced SNc dopaminergic neurons and dorsal striatum dopamine terminals were observed in TN(-/-) mice compared to wild type.

Conclusions:

  • The TN(-/-) mouse model recapitulates key pathological and clinical features of Parkinson disease.
  • This model provides a valuable tool for investigating LB formation mechanisms.
  • The TN(-/-) mouse is suitable for testing potential neuroprotective therapies for PD and other synucleinopathies.